Snahel Patel
5PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 30, 2025
Discovery of Clinical Candidate GDC-8264, a Novel, Potent and Selective RIP1 Inhibitor for Amelioration of Tissue Damage and the Treatment of Inflammatory Diseases.Snahel Patel, Huifen Chen, Eugene Varfolomeev
|Jul 20, 2022
Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse model of dilated cardiomyopathy.Jin Yang, Francis Grafton, Sara Ranjbarvaziri
|Nov 15, 2021
Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors.Dennis X Hu, Snahel Patel, Huifen Chen
|May 19, 2019
RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases.Snahel Patel, Joshua D Webster, Eugene Varfolomeev
|Aug 18, 2017
Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease.Claire E Le Pichon, William J Meilandt, Sara Dominguez
Pageof 1
Frequent Collaborators
3 joint publications
Michael Siu
2 joint publications
Huifen Chen
2 joint publications
Adam Johnson
1 joint publications
Claire E Le Pichon
1 joint publications
William J Meilandt
1 joint publications
Han Lin
1 joint publications
Alvin Gogineni
1 joint publications
Seung-Hye Lee
1 joint publications
Janice Maloney
1 joint publications
Patrick Lupardus
